Humana Inc. (HUM) Revenue by Segment

Humana revenue by segment at a glance

In Q2 fiscal 2026 (the quarter ended June 30, 2026), Humana's largest business segment was Insurance, with $39.14 billion or 85% of revenue, up 25.9% from a year earlier. Next: CenterWell (15%).

By customer type, Medicare brought in 82%, Medicaid and Other brought in 8% and Group Medicare Advantage brought in 6% of revenue in Q2 fiscal 2023.

The fastest-growing business segment from a year earlier was Insurance (+25.9%).

From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q3 fiscal 2017.

Humana Inc.

HUMHealthcare

United States

Healthcare

Revenue breakdown

Fiscal quarters, from company filings

Segments by quarter (USD)

Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i

InsuranceRetailHealthcare ServicesCenterWellGroup and SpecialtyIndividual CommercialReconciling itemsCorporate and Eliminations

Q2 FY26 breakdown

Fiscal quarter ended Jun 30, 2026

Item	Revenue	Share	vs year before
Insurance	USD 39.14B	85.2%	+25.9%
CenterWell	USD 6.79B	14.8%	+22.6%
Corporate and Eliminationsi	-USD 5.06B		–

Sum of items USD 45.93B; corporate items and eliminations -USD 5.06B. Shares are of the items shown. Click an item with › to see its parts.

Also reported by:

All periods

Every item and period in one grid. Purple = calculated; "–" = not available.

Item	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q3 FY22	Q2 FY22	Q1 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19	Q4 FY18	Q3 FY18	Q2 FY18	Q1 FY18	Q4 FY17	Q3 FY17
Insurance	39.1B	38.1B	31.3B	31.2B	31.1B	30.9B	28.2B	28.4B	28.5B	28.7B	25.6B	25.5B	25.9B	25.9B	80.0M	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Retail	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	20.2B	20.9B	21.3B	18.4B	18.4B	18.5B	18.6B	16.8B	16.7B	17.0B	16.8B	–	14.1B	14.2B	14.0B	12.0B	12.1B	12.0B	12.1B	–	11.0B
Healthcare Services	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.1B	1.1B	1.0B	647.0M	7.5B	7.2B	275.0M	7.1B	6.9B	7.1B	–	6.6B	6.4B	6.1B	169.0M	6.0B	6.0B	5.7B	–	6.0B
CenterWell	6.8B	6.1B	6.0B	5.9B	5.5B	5.1B	5.1B	5.0B	4.9B	4.8B	4.7B	4.7B	4.5B	4.5B	2.0M	4.3B	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Group and Specialty	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.6B	1.6B	1.6B	1.7B	1.7B	1.7B	1.7B	1.8B	1.8B	1.8B	1.9B	–	1.9B	1.9B	1.9B	1.9B	1.9B	1.9B	2.0B	–	1.9B
Individual Commercial	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.0M	1.0M	10.0M	- 5.0M	–	225.0M
Reconciling items	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	14.0M	76.0M	46.0M	–	32.0M
Corporate and Eliminations	- 5.1B	- 4.5B	- 4.8B	- 4.4B	- 4.2B	- 3.9B	- 4.1B	- 4.0B	- 3.9B	- 3.9B	- 3.8B	- 3.7B	- 3.7B	- 3.7B	78.0M	- 3.2B	–	–	–	–	- 7.1B	- 6.9B	–	- 5.6B	- 6.7B	- 6.8B	–	- 6.3B	- 6.2B	- 5.9B	–	- 5.7B	- 5.8B	- 5.5B	–	- 5.9B

Humana revenue by business segment, last 4 quarters

Business segment	Q2 FY26	Q1 FY26	Q3 FY25	Q2 FY25	Share
Insurance	$39.1B	$38.1B	$31.2B	$31.1B	85%
CenterWell	$6.8B	$6.1B	$5.9B	$5.5B	15%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Humana revenue by customer type, last 4 quarters

Customer type	Q2 FY23	Q1 FY23	Q3 FY22	Q2 FY22	Share
Medicare	$22.0B	$22.2B	$18.3B	–	82%
Medicaid and Other	$2.1B	$1.9B	$1.6B	$1.6B	8%
Group Medicare Advantage	$1.7B	–	–	$1.9B	6%
Specialty Benefits	$252.0M	–	–	$261.0M	1%
Pharmacy Solutions	$216.0M	$242.0M	$274.0M	$254.0M	1%
Provider Services	$190.0M	$201.0M	–	$137.0M	1%
Medicare Supplement Product	$182.0M	$179.0M	–	$185.0M	1%
Commercial ASO	$64.0M	$71.0M	–	$75.0M	under 1%

In USD, fiscal quarters as reported; share = part of Q2 FY23 revenue.

Questions and answers

What are Humana's business segments?

Insurance and CenterWell (as reported for Q2 fiscal 2026).

Which business segment makes the most money for Humana?

Insurance: $39.14 billion, or 85% of revenue, in Q2 fiscal 2026.

MoreHumana stock overview Humana financials Humana executive team Humana shareholders

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.